Back to search

Article

Integrated bioinformatics analysis reveals ISG15, IFIH1, OAS2, MX1, and CXCL10 as predictive biomarkers of neoadjuvant chemotherapy response in triple-negative breast cancer

2026-03-02

Abstract excerpt

<title>Abstract</title> <p> Background: The prognosis for triple-negative breast cancer (TNBC), an aggressive subtype of breast cancer, is challenging, and there are few available treatments. Despite neoadjuvant chemotherapy (NAC) being the prevalent treatment, it has a wide range of side effects. Hence, identifying predictive indicators of NAC response could enhance treatment selection and outcomes. <h4>Method...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5af0680c-df95-58e6-9c07-a7fad0f3d50f
DOI
10.21203/rs.3.rs-8937161/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Integrated bioinformatics analysis reveals ISG15, IFIH1, OAS2, MX1, and CXCL10 as predictive biomarkers of neoadjuvant chemotherapy response in triple-negative breast cancerDOI 10.21203/rs.3.rs-8937161/v1
Identification of DDIT4 as a Potential Prognostic Marker Associated with Chemotherapy and Immunotherapy Response in Triple-Negative Breast CancerSemantic proximity
Integration of multi-omics data shows downregulation of mismatch repair, purin, and tubulin pathways in triple-negative chemotherapy-resistant breast tumorsSemantic proximity
Integration of multi-omics data shows downregulation of mismatch repair, purin, and tublin pathways in AR-negative triple-negative chemotherapy-resistant breast tumorsSemantic proximity
Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancerSemantic proximity
Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancerSemantic proximity
A novel twelve-gene signature to evaluate neoadjuvant chemotherapy response and predict prognosis in breast cancerSemantic proximity
Drug-Gene Network Signature Modeling Predicts Breast Cancer Patient Response to Neoadjuvant ChemotherapySemantic proximity
Genomic and transcriptomic analysis of breast cancer identifies novel signatures associated with response to neoadjuvant chemotherapySemantic proximity
Identification of A 10-Gene Signature To Predict Efficacy of Neoadjuvant Therapy in Patients With HER2 Positive Breast Cancer.Semantic proximity
Identification of immune-related biomarkers for predicting neoadjuvant chemotherapy sensitivity in HER2 negative breast cancer via bioinformatics analysisSemantic proximity
Identifying Hub Genes Associated with Neoadjuvant Chemotherapy Resistance in Breast Cancer and Potential Drug Repurposing for the Development of Precision MedicineSemantic proximity
Identification of a 10-Gene Signature Model to Predict Efficacy of Neoadjuvant Therapy in Patients With HER2&nbsp;Positive Breast Cancer.Semantic proximity
Select a neighboring publication to make it the new centre.